These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 10350383

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. International study comparing cefdinir and cefuroxime axetil in the treatment of patients with acute exacerbation of chronic bronchitis.
    Van Herwaarden CL, Langan CE, Siemon G, Rudolph C, Keyserling CH, Nemeth MA, Tack KJ.
    Int J Infect Dis; 2000; 4(1):26-33. PubMed ID: 10689211
    [Abstract] [Full Text] [Related]

  • 25. Comparative study of cefaclor AF vs. cefuroxime axetil in acute exacerbations of chronic bronchitis.
    Haczyński J, Chyczewska E, Grzelewska-Rzymowska I, Malolepszy J, Marcinkowska-Suchowierska E, Milanowski J, Oklek K, Płusa T, Słominski J, Szmygin K, Rek M.
    Med Sci Monit; 2002 Jan; 8(1):PI1-7. PubMed ID: 11782685
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
    Perry CM, Brogden RN.
    Drugs; 1996 Jul; 52(1):125-58. PubMed ID: 8799689
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
    DeAbate CA, Henry D, Bensch G, Jubran A, Chodosh S, Harper L, Tipping D, Talbot GH.
    Chest; 1998 Jul; 114(1):120-30. PubMed ID: 9674458
    [Abstract] [Full Text] [Related]

  • 31. Short-course cefuroxime axetil therapy in the treatment of acute exacerbations of chronic bronchitis.
    Langan C, Clecner B, Cazzola CM, Brambilla C, Holmes CY, Staley H.
    Int J Clin Pract; 1998 Jul; 52(5):289-97. PubMed ID: 9796558
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia.
    Norrby SR, Petermann W, Willcox PA, Vetter N, Salewski E.
    Scand J Infect Dis; 1998 Jul; 30(4):397-404. PubMed ID: 9817522
    [Abstract] [Full Text] [Related]

  • 34. Comparison of single-dose cefuroxime axetil with ciprofloxacin in treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing Neisseria gonorrhoeae strains.
    Thorpe EM, Schwebke JR, Hook EW, Rompalo A, McCormack WM, Mussari KL, Giguere GC, Collins JJ.
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2775-80. PubMed ID: 9124839
    [Abstract] [Full Text] [Related]

  • 35. Oral gemifloxacin once daily for 5 days compared with sequential therapy with i.v. ceftriaxone/oral cefuroxime (maximum of 10 days) in the treatment of hospitalized patients with acute exacerbations of chronic bronchitis.
    Wilson R, Langan C, Ball P, Bateman K, Pypstra R, Gemifloxacin 207 Clinical Study Group.
    Respir Med; 2003 Mar; 97(3):242-9. PubMed ID: 12645831
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Clinical comparison of cefuroxime axetil, cephalexin and cefadroxil in the treatment of patients with primary infections of the skin or skin structures.
    Gooch WM, Kaminester L, Cole GW, Binder R, Morman MR, Swinehart JM, Wisniewski M, Yilmaz HM, Collins JJ.
    Dermatologica; 1991 Mar; 183(1):36-43. PubMed ID: 1769413
    [Abstract] [Full Text] [Related]

  • 38. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
    Perry CM, Scott LJ.
    Drugs; 2004 Mar; 64(13):1433-64. PubMed ID: 15212560
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.